Acessibilidade / Reportar erro

Purpuric rash on the legs of a patient with coronavirus disease

A 30-year-old male health-care worker, who was regularly monitored at the dermatology clinic for ochre dermatitis on the medial side of the legs, reported a 15-day history of fever and diarrhea, followed by erythematous-purpuric macules and papules on the legs and feet 1 week before, involving some fingers (Figures 1A and B). He had no history of pain or itching. After 2 weeks, he returned to the clinic after testing for coronavirus disease (COVID-19) antibodies (IgM and IgG positive). The skin lesions showed considerable improvement during this period (Figure 1C) and the patient fully recovered at home.

FIGURE 1:
(A): Purpuric rashes on the anterior surface of the legs. (B): Characteristics of the lesions in the toes, resembling perniosis. (C): Clinical improvement after 2 weeks of expectant management.

The patient' clinical condition was considered a vascular skin manifestation associated with COVID-19 infection11. Galvan CC, Catala A, Carretero HG, Rodríguez-Jiménez P, Ferández-Nieto D, Rodríguez-Villa LA, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020.,22. Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Takeshita J, et al. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries. J Am Acad Dermatol. 2020;83(2):486-92.. Among the specific dermatological findings of the disease, pernio-like lesions are highlighted22. Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Takeshita J, et al. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries. J Am Acad Dermatol. 2020;83(2):486-92.. Perniosis is a vascular inflammatory response occurring in the extremities and is clinically characterized by erythematous-purpuric macules and papules. This skin condition can be induced by low temperatures or can be associated with autoimmune diseases, drugs, or infections. When associated to COVID-19, pernio-like lesions are predominantly manifest in young and healthy patients, which may represent a good prognosis of the infectious condition22. Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Takeshita J, et al. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries. J Am Acad Dermatol. 2020;83(2):486-92.,33. Bouaziz JD, Duong T, Jachiet M, Velter C, Lestang P, Cassius C, et al. Vascular skin symptoms in COVID-19: a French observational study. J Eur Acad Dermatol Venereol. 2020..

Severe acute respiratory syndrome coronavirus 2 infection can affect several organ systems, including the skin11. Galvan CC, Catala A, Carretero HG, Rodríguez-Jiménez P, Ferández-Nieto D, Rodríguez-Villa LA, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020.. As Brazil is one of the most affected countries, recognizing associated skin lesions is important for the early diagnosis of COVID-19.

REFERENCE

  • 1
    Galvan CC, Catala A, Carretero HG, Rodríguez-Jiménez P, Ferández-Nieto D, Rodríguez-Villa LA, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020.
  • 2
    Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Takeshita J, et al. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries. J Am Acad Dermatol. 2020;83(2):486-92.
  • 3
    Bouaziz JD, Duong T, Jachiet M, Velter C, Lestang P, Cassius C, et al. Vascular skin symptoms in COVID-19: a French observational study. J Eur Acad Dermatol Venereol. 2020.

Publication Dates

  • Publication in this collection
    21 Sept 2020
  • Date of issue
    2020

History

  • Received
    10 July 2020
  • Accepted
    18 Aug 2020
Sociedade Brasileira de Medicina Tropical - SBMT Caixa Postal 118, 38001-970 Uberaba MG Brazil, Tel.: +55 34 3318-5255 / +55 34 3318-5636/ +55 34 3318-5287, http://rsbmt.org.br/ - Uberaba - MG - Brazil
E-mail: rsbmt@uftm.edu.br